Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot assays have demonstrated that HOXC13 is highly expressed in cervical cancer [24], metastatic melanoma, liposarcoma, glioblastoma, sarcomas, and esophageal, skin, prostate [25,26], and breast cancers [27]. This evidence concerns the gene HOXC13 and cervical carcinoma.